76 related articles for article (PubMed ID: 6642131)
1. [The treatment of thyroid carcinoma. Results of 19 years' use of I-131].
Gordon F; Juan-Marcos H; Muñoz R
Gac Med Mex; 1983 Sep; 119(9):356-60. PubMed ID: 6642131
[No Abstract] [Full Text] [Related]
2. 131I dosimetry and thyroid stunning.
Gerard SK; Park HM
J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
[No Abstract] [Full Text] [Related]
3. [Radiotherapy of struma maligna].
Engelken G; Hymmen U; Schenck P; Wieland C
Chirurg; 1976 Aug; 47(8):435-8. PubMed ID: 821730
[No Abstract] [Full Text] [Related]
4. [Guidelines and results in the treatment of thyroid cancer].
Ortíz Berrocal J; Sopena Monforte R; Carril Carril JM; Ramos Sánz J; Martínez R; Chamorro Romero JL
Rev Clin Esp; 1977 Jun; 145(5):361-8. PubMed ID: 877349
[No Abstract] [Full Text] [Related]
5. [Radioactive iodine in the treatment of thyroid carcinoma].
Pendić S; Tasić S
Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
[No Abstract] [Full Text] [Related]
6. [Results obtained in the treatment of hyperfunctional thyroid adenomas with I-131].
Holan T; Micluţia M; Derevenco V
Stud Cercet Endocrinol; 1972; 23(4):271-9. PubMed ID: 4681160
[No Abstract] [Full Text] [Related]
7. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
Tsyb AF; Drozdovskiĭ BI; Proshin VV
Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of radioactive iodine in the treatment of toxic adenoma: results of our experience with a group of 17 patients and review of the literature].
Melián E; Cuellar L; Estopiñán V; Riobó P; Lara JI; Sánchez-Franco F
Med Clin (Barc); 1988 Mar; 90(9):366-8. PubMed ID: 3292865
[No Abstract] [Full Text] [Related]
9. Adjuvant treatment of thyroid cancer.
Beauduin M; Hermans J; Majois F
Acta Otorhinolaryngol Belg; 1987; 41(5):944-5. PubMed ID: 3454107
[No Abstract] [Full Text] [Related]
10. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of carcinoma of the thyroid.
Howard N; Smithers DW
Monogr Neoplast Dis Var Sites; 1970; 6():259-68. PubMed ID: 5527677
[No Abstract] [Full Text] [Related]
13. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
14. [Malignant goiter. Retrospective analysis of the patient material and treatment results at the Division of Nuclear Medicine of the 2nd Medical Department of Vienna University from 1973 to 1982].
Weissel M; Bergmann H; Steidler B; Keminger K; Krisch K; Niederle B; Roka R; Schmalzer E; Willvonseder R; Höfer R
Acta Med Austriaca; 1983; 10(2-3):83-91. PubMed ID: 6880577
[No Abstract] [Full Text] [Related]
15. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
[No Abstract] [Full Text] [Related]
16. [Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation].
Liu RT; Huang MJ; Huang HS; Huang BY; Lin JD; Wang PW; Tzen KY
Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):524-8. PubMed ID: 3625158
[No Abstract] [Full Text] [Related]
17. [Effect of the plan of therapy on prognosis in thyroid cancer].
Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
[TBL] [Abstract][Full Text] [Related]
18. The place of ionizing radiation in the treatment of thyroid carcinoma.
Millburn L; Ameen D
Otolaryngol Clin North Am; 1980 Feb; 13(1):109-13. PubMed ID: 7366995
[TBL] [Abstract][Full Text] [Related]
19. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
[No Abstract] [Full Text] [Related]
20. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
Robbins RJ; Pentlow KS
J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
